Greene John

10% owner at ETRIALS WORLDWIDE INC. · on record since Jan 6, 2010
CVP & Chief Financial Officer at NORTHROP GRUMMAN CORP /DE/ · on record since Feb 13, 2026
EVP, CFO and Treasurer at Bioverativ Inc. · on record since Dec 22, 2016
Director at CRISPR Therapeutics AG · on record since Jun 9, 2026
Chief Financial Officer at WILLIS TOWERS WATSON PLC · on record since Jun 12, 2014
See Remarks at WILLIS TOWERS WATSON PLC · on record since Jan 6, 2016
EVP, Chief Financial Officer at Discover Financial Services · on record since Sep 20, 2019

Insider trading activity of Greene John

Transactions on record: 58; since Aug 13, 2014

Open-market buys: 2; $563.3K

Open-market sells: 2; $4.3M

Companies traded: 5; last filing Jun 9, 2026

Figures computed from official regulatory filings — .

Companies where Greene John has traded

CRISPR Therapeutics AG9 tx · $314K · Jun 9, 2026
NORTHROP GRUMMAN CORP /DE/2 tx · Feb 13, 2026
Discover Financial Services26 tx · $12M · May 19, 2025
Bioverativ Inc.14 tx · $219.3K · Mar 8, 2018
WILLIS TOWERS WATSON PLC7 tx · $35.5K · Jan 6, 2016

Track record of Greene John

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Greene John

Co-insiders of Greene John

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CRISPR Therapeutics AGListing on record	Jun 9, 2026	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NORTHROP GRUMMAN CORP /DE/Listing on record	Feb 13, 2026	AwardD (derivative)	4,981	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NORTHROP GRUMMAN CORP /DE/Listing on record	Feb 13, 2026	AwardD (derivative)	5,362	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Jun 6, 2025	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	May 19, 2025	Other	-79,943	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Feb 28, 2025	Buy	7,000	44.85 USD	$314K	conv 74First in 12mo	SEC
Discover Financial ServicesListing unverified	Feb 4, 2025	Other	-1,840	201.09 USD	$370K		SEC
Discover Financial ServicesListing unverified	Jan 27, 2025	Award	14,630	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Dec 23, 2024	Award	12,109	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Dec 23, 2024	Other	-11,702	169.27 USD	$2M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	May 31, 2024	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 26, 2024	Award	9,051	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 26, 2024	Award	29,324	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Award	21,801	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Other	-12,290	106.56 USD	$1.3M		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Other	-12,290	106.56 USD	$1.3M		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Award	21,801	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Jan 30, 2024	Sell	-35,191	106.51 USD	$3.7M		SEC
CRISPR Therapeutics AGListing on record	Jun 9, 2023	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 27, 2023	Award	9,960	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 3, 2023	Award	25,196	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 3, 2023	Other	-14,083	115.83 USD	$1.6M	Unusual size	SEC
Discover Financial ServicesListing unverified	Aug 3, 2022	Other	-1,752	102.22 USD	$179.1K		SEC
CRISPR Therapeutics AGListing on record	Jun 10, 2022	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Mar 1, 2022	Award	7,339	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CRISPR Therapeutics AGListing on record	Jun 9, 2026	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NORTHROP GRUMMAN CORP /DE/Listing on record	Feb 13, 2026	AwardD (derivative)	4,981	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NORTHROP GRUMMAN CORP /DE/Listing on record	Feb 13, 2026	AwardD (derivative)	5,362	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Jun 6, 2025	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	May 19, 2025	Other	-79,943	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Feb 28, 2025	Buy	7,000	44.85 USD	$314K	conv 74First in 12mo	SEC
Discover Financial ServicesListing unverified	Feb 4, 2025	Other	-1,840	201.09 USD	$370K		SEC
Discover Financial ServicesListing unverified	Jan 27, 2025	Award	14,630	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Dec 23, 2024	Award	12,109	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Dec 23, 2024	Other	-11,702	169.27 USD	$2M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	May 31, 2024	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 26, 2024	Award	9,051	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 26, 2024	Award	29,324	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Award	21,801	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Other	-12,290	106.56 USD	$1.3M		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Other	-12,290	106.56 USD	$1.3M		SEC
Discover Financial ServicesListing unverified	Feb 5, 2024	Award	21,801	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Jan 30, 2024	Sell	-35,191	106.51 USD	$3.7M		SEC
CRISPR Therapeutics AGListing on record	Jun 9, 2023	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 27, 2023	Award	9,960	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 3, 2023	Award	25,196	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Feb 3, 2023	Other	-14,083	115.83 USD	$1.6M	Unusual size	SEC
Discover Financial ServicesListing unverified	Aug 3, 2022	Other	-1,752	102.22 USD	$179.1K		SEC
CRISPR Therapeutics AGListing on record	Jun 10, 2022	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Discover Financial ServicesListing unverified	Mar 1, 2022	Award	7,339	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC